Blood pressure responses to hypertension treatment and trends in cognitive function in patients with initially difficult-to-treat hypertension: a retrospective subgroup analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) study

J Clin Hypertens (Greenwich). 2012;14:78–84. ©2012 Wiley Periodicals, Inc.The Observational Study on Cognitive Function and SBP Reduction (OSCAR) provided opportunities to examine the influence of eprosartan on trends in cognitive performance in a large population of patients with difficult‐to‐treat hypertension (DTTH). A total of 4649 patients diagnosed retrospectively with DTTH, defined as systolic/diastolic blood pressure (SBP/DBP) ≥140/90 mm Hg despite use of at least 3 antihypertensive drugs during the month preceding the baseline visit comprised the intention‐to‐treat (ITT) cohort. The patients were given eprosartan‐based antihypertension therapy (EBT; 600 mg/d). Blood pressure and cognitive function parameters included significant (P<.001) differences for DTTH vs non‐DTTH patients such as older age, body mass index, SBP and pulse pressure (PP), and lower Mini‐Mental State Examination (MMSE) score. After EBT for 6 months, SBP/DBP in DTTH was 138.8±12.2/81.9±7.4 (ΔSBP−26±15.7; ΔDBP−11.4±9.8); PP was 57.0±10.8 (ΔPP−14.5±13.8) (all P<.001 vs baseline and non‐DTTH group). A total of 2576 patients (87.4%) responded to EBT (ie, SBP <140 mm Hg and/or ΔSBP ≥15 mm Hg, or DBP <90 mm Hg and/or ΔDBP ≥10 mm Hg); 1426 DTTH patients (48.4%) achieved normalized SBP/DBP (ie, SBP <140 mm Hg and DBP <90 mm Hg). ΔPP in DTTH‐isolated systolic hypertension (ISH) was −18.0±13.3 mm Hg (P=.003 vs DTTH‐systolic‐diastolic hypertension). End‐of‐EBT mean MMSE was 27.5±3.0 (P<.001 vs baseline). Blood pressure responses after EBT coincided with stabilization/improvement of MMSE in this retrospective investigation in DTTH patients. The average improvement in MMSE in DTTH patients was similar to that in non‐DTTH patients. EBT effects on PP may be relevant to the evolution of MMSE in DTTH‐ISH patients.

The Observational Study on Cognitive Function and SBP Reduction (OSCAR) was designed to examine the safety and tolerability of once‐daily therapy with eprosartan in a very large community‐dwelling population of patients with arterial hypertension recruited in 28 countries and managed in routine primary care. This study provided opportunities to examine the influence of the angiotensin receptor blocker (ARB) eprosartan on trends in cognitive performance in a large population of patients with high blood pressure (BP).The principal findings of OSCAR have been reported previously. ¹ A 6‐month period of antihypertensive therapy based on eprosartan was associated with a significant reduction in mean systolic BP (SBP) and a significant improvement in mean Mini‐Mental State Examination (MMSE) score (P<.0001 for both outcomes). In multiple linear regression, cognitive decline was demonstrated to be independently and inversely correlated with SBP reduction (odds ratio, 0.77; 95% confidence interval [CI], 0.73–0.82).The intention‐to‐treat (ITT) cohort of OSCAR comprised 25,745 adult patients with hypertension. This large number of patients enabled us to identify several large subgroups for further investigation, with the intention of adding to what are still sometimes limited epidemiologic data on specific types of patients.Recent revisions to extant European hypertension guidelines and first reports of new treatment options for this condition ² , ³ , ⁴ are indications that resistant hypertension is a pressing clinical priority. Poorly controlled high BP may be a factor in cognitive decline in older patients. Observations from several thousand patients in a real‐world survey may be instructive for the better management of this condition. Accordingly, we report here our findings in a retrospectively identified cohort of almost 3000 patients from the OSCAR population classified as having difficult‐to‐treat hypertension (DTTH) at baseline.